Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas [5]

B. Falini, D. Lenze, R. Hasserjian, S. Coupland, D. Jaehne, C. Soupir, A. Liso, M. P. Martelli, N. Bolli, F. Bacci, V. Pettirossi, A. Santucci, M. F. Martelli, S. Pileri, H. Stein

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1566-1570
Number of pages5
Issue number7
Publication statusPublished - Jul 2007

ASJC Scopus subject areas

  • Hematology
  • Cancer Research

Cite this